Rafferty Asset Management, LLC Acadia Pharmaceuticals Inc Transaction History

Rafferty Asset Management, LLC

$22.9 Billion
Q1 2025

A detailed history of Rafferty Asset Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 200,289 shares of ACAD stock, worth $4.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

200,289

Previous 150,234 33.32%

Holding current value

$4.32 Million

Previous $2.76 Million 20.68%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$16.61 - $20.29 $831,413 - $1.02 Million	50,055 Added 33.32%	200,289 $3.33 Million
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $1.94 Million - $2.54 Million	-135,507 Reduced 47.42%	150,234 $2.76 Million
Q3 2024 Nov 13, 2024	SELL	$15.14 - $19.14 $292,777 - $370,129	-19,338 Reduced 6.34%	285,741 $4.4 Million
Q2 2024 Aug 13, 2024	SELL	$14.62 - $18.42 $1.26 Million - $1.59 Million	-86,146 Reduced 22.02%	305,079 $4.96 Million
Q1 2024 May 13, 2024	SELL	$17.79 - $30.86 $652,981 - $1.13 Million	-36,705 Reduced 8.58%	391,225 $7.23 Million
Q4 2023 Feb 13, 2024	BUY	$20.78 - $31.77 $1.9 Million - $2.9 Million	91,317 Added 27.13%	427,930 $13.4 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $12,170 - $19,546	584 Added 0.17%	336,613 $7.02 Million
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $65,290 - $94,084	3,668 Added 1.1%	336,029 $8.05 Million
Q1 2023 May 11, 2023	SELL	$16.32 - $20.92 $3.66 Million - $4.69 Million	-224,320 Reduced 40.3%	332,361 $6.26 Million
Q4 2022 Feb 13, 2023	BUY	$14.2 - $18.63 $2.24 Million - $2.94 Million	158,005 Added 39.63%	556,681 $8.86 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $2.47 Million - $3.2 Million	175,222 Added 78.42%	398,676 $6.52 Million
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $94,049 - $196,773	-7,229 Reduced 3.13%	223,454 $3.15 Million
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $130,142 - $170,912	-6,215 Reduced 2.62%	230,683 $5.59 Million
Q4 2021 Feb 10, 2022	BUY	$16.79 - $27.09 $725,831 - $1.17 Million	43,230 Added 22.32%	236,898 $5.53 Million
Q3 2021 Nov 10, 2021	BUY	$15.78 - $24.77 $1.55 Million - $2.44 Million	98,537 Added 103.58%	193,668 $3.22 Million
Q2 2021 Aug 10, 2021	SELL	$19.4 - $27.42 $544,965 - $770,255	-28,091 Reduced 22.8%	95,131 $2.32 Million
Q1 2021 May 10, 2021	BUY	$25.02 - $54.99 $2.63 Million - $5.78 Million	105,036 Added 577.57%	123,222 $3.18 Million
Q4 2020 Feb 10, 2021	SELL	$41.04 - $56.79 $1.48 Million - $2.04 Million	-35,995 Reduced 66.43%	18,186 $972,000
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $1.21 Million - $1.9 Million	33,346 Added 160.05%	54,181 $2.24 Million
Q2 2020 Aug 07, 2020	BUY	$39.26 - $52.73 $409,364 - $549,815	10,427 Added 100.18%	20,835 $1.01 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $2.47 Million - $3.66 Million	-78,071 Reduced 88.24%	10,408 $440,000
Q4 2019 Feb 10, 2020	SELL	$36.21 - $51.4 $1.27 Million - $1.81 Million	-35,204 Reduced 28.46%	88,479 $3.79 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $1.72 Million - $3.41 Million	-77,572 Reduced 38.54%	123,683 $4.45 Million
Q2 2019 Aug 09, 2019	BUY	$23.32 - $28.12 $203,700 - $245,628	8,735 Added 4.54%	201,255 $5.38 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $3.11 Million - $5.27 Million	192,520 New	192,520 $5.17 Million

Others Institutions Holding ACAD

# of Institutions

351

Shares Held

165M

Call Options Held

1.77M

Put Options Held

307K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.49B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Acadia Pharmaceuticals Inc Transaction History